Skip to main content
Clinical Trials/NCT02098382
NCT02098382
Completed
Not Applicable

Prospective Collection of Data About the Use of the Dilapan-S Osmotic Dilator in Pre-induction of Labor in Women With/Without Caesarean Section in Their History

Medicem International CR s.r.o.1 site in 1 country125 target enrollmentMay 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uterine Cervical Incompetence
Sponsor
Medicem International CR s.r.o.
Enrollment
125
Locations
1
Primary Endpoint
Cervix (Bishop) score
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Non-interventional prospective data collection designed to evaluate clinical outcome on the efficacy of the use of Dilapan-S in the indication of labor pre-induction in women with/without a history of Caesarean section. The evaluation will be based on prospective data collection in at least four obstetrics centers in the Czech Republic.

Detailed Description

Nowadays there is a rising need for non-pharmacological cervical ripening methods as the use of prostaglandins is frequently limited by various contraindications. Dilapan-S is a hygroscopic uterine neck dilator. Its mode of action consists in the hydrophilic properties of the device absorbing fluids from surrounding tissue structures, thus expanding the volume of Dilapan-S sticks which subsequently exert radial pressure on the surrounding structures (uterine neck) to dilate progressively. Endocervical pressure on the uterine neck results not only in its mechanical dilatation but pressure on endocervical structures also stimulates the production of endogenous prostaglandins, which promote cervical ripening through its collagenolytic action. Although Dilapan-S is widely used in labor pre-induction, published study data comparing its clinical efficacy and safety in females with/without caesarean section in medical history are lacking.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
October 2014
Last Updated
10 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Single pregnancy
  • Pregnancy more than 36 weeks
  • Vertex presentation of the fetus
  • Cervix Score less than 4 points

Exclusion Criteria

  • Contraindication to vaginal delivery
  • Pathological fetal station
  • States after uterine body surgery - except for Caesarean section
  • Clinical signs of uterine, vaginal or vulvar infection
  • Fetus hypoxia (KTG recording evaluated as pathological prior to pre-induction initiation)

Outcomes

Primary Outcomes

Cervix (Bishop) score

Time Frame: Before pre-induction of labor performance and up to 24 h after pre-induction of labor

To evaluate, based on the value obtained in the Cervix Score, the efficacy of use of the Dilapan-S device in the indication labor pre-induction, and to compare outcomes in patients with/without a history of Caesarean section.

Secondary Outcomes

  • Total duration of pre-induction(From Dilapan-S rods insertion up to 24 hours)
  • Number of dilators inserted(At the moment of Dilapan-S insertion up to 24 hours until their removal)
  • Apgar score(At 1st, 5th and 10th minute after delivery)
  • The course of delivery (vaginally or Caesarean section)(From active phase of labor up to 1 day after delivery)
  • Uterine contractions(From Dilapan-S rods insertion up to 24 h during pre-induction of labor phase)
  • pH of the fetus(Up to 10 minutes after delivery)
  • Infection complications of mother / fetus(Up to 5 days from the birth)

Study Sites (1)

Loading locations...

Similar Trials